false000175419500017541952025-03-062025-03-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM 8-K
___________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): March 6, 2025
___________________
TRULIEVE CANNABIS CORP.
(Exact Name of Registrant as specified in its charter)
___________________
British Columbia000-5624884-2231905
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
6749 Ben Bostic Road
Quincy, FL 32351
(Address of principal executive offices and zip code)

(850) 298-8866
(Registrant’s telephone number, including area code)
Not Applicable
(Registrant’s name or former address, if change since last report)
___________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
N/AN/AN/A
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. o


Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Resignation of Wes Getman as Chief Financial Officer and appointment of Ryan Blust as Interim Chief Financial Officer

On March 6, 2025, Wes Getman resigned from his position as Chief Financial Officer of Trulieve Cannabis Corp. (the “Company”) to pursue other opportunities. Mr. Getman did not receive any severance in connection with his departure and his departure is not based on any disagreement with the Company regarding accounting principles, practices or financial statement disclosures. The Company has retained the services of an executive recruitment firm to commence a search for a new chief financial officer. The Company has appointed Ryan Blust, the Company’s Vice President, Finance, as its interim Chief Financial Officer, effective immediately. There will be no increase in Mr. Blust’s compensation as a result of his serving as Interim Chief Financial Officer.

Mr. Blust, age 48, has over 20 years accounting and finance experience. Mr. Blust joined the Company in September 2018 and has previously served three times as interim Chief Financial Officer for the Company. Prior to joining the Company, Mr. Blust served as the Controller at Vector Solutions, a software company. Mr. Blust also served as Chief Financial Officer for Honeycomb Company of America, an aerospace manufacturer, and as Assistant Controller for Marinemax, a retail boat company. He began his career in public accounting in 2004, serving with both Cherry Bekaert as well as Bobbitt, Pittinger & Company.

Mr. Blust previously entered into an employment agreement with the Company, dated September 29, 2021 (the “Blust Employment Agreement”), pursuant to which, he receives an annual base salary of $270,000 per year that is paid in accordance with the Company’s regular payroll practices, subject to all customary withholding and deductions, and will also be eligible for an annual bonus targeted at 40% and up to 80% of base salary based on the achievement of certain Company and individual performance goals to be established by the Compensation and Human Resources Committee. Mr. Blust will also be eligible for equity award grants in a manner consistent with the Company’s practices for senior management and will also be entitled to participate in the Company’s employee benefits programs available to its employees generally. In addition, Mr. Blust will be entitled to participate in other benefits that are available to our executive officers on the same basis as all our employees generally, including group health (medical, dental, and vision) insurance, group short- and long-term disability insurances, and group life insurance. Such compensation and benefit plans and arrangements are described in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 29, 2024. The Blust Employment Agreement also includes provisions for separation payments and benefits upon certain types of termination of employment as well as standard confidentiality, non-competition, non-solicitation, non disparagement and intellectual property assignment provisions.

Except as set forth in the Blust Employment Agreement, (a) there are no arrangements or understandings between Mr. Blust and any other persons pursuant to which Mr. Blust was appointed, (b) there are no family relationships among any of the Company’s directors or executive officers and Mr. Blust, and (c) Mr. Blust has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

The foregoing descriptions of the Blust Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such agreement, which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q to be filed for the quarter ending March 30, 2025.

Item 7.01    Regulation FD Disclosure.

On March 7, 2025, the Company issued a press release announcing the appointment of Mr. Blust as interim Chief Financial Officer. A copy of the press release is furnished as Exhibit 99.1 hereto.

The information set forth in this Item 7.01 and Exhibit 99.1 shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in any of the Company’s filings under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.



Item 9.01.    Financial Statements and Exhibits.

(d)Exhibits

Exhibit
No.		Description
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Trulieve Cannabis Corp.
By:/s/ Eric Powers
Name:Eric Powers
Title:Chief Legal Officer
Date: March 7, 2025


image.jpg
Trulieve Announces Appointment of Ryan Blust
as Interim Chief Financial Officer


TALLAHASSEE, Fla. – March 7, 2025 – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the appointment of Ryan Blust, the Company’s Vice President, Finance, as its interim Chief Financial Officer and the departure of Wes Getman as Chief Financial Officer to pursue other opportunities, each effective March 6, 2025. The Company has also retained the services of an executive recruitment firm to commence a search for a new chief financial officer prepared to make strategic contributions to the Company.

“We thank Wes for his good work, particularly with his team implementing robust financial controls to meet Sarbanes Oxley requirements last year,” said Trulieve's Chief Executive Officer Kim Rivers. “Ryan has been with Trulieve since 2018, providing valuable expertise and leadership throughout his tenure, including previously stepping into the role when called upon. We look forward to working closely with Ryan and the team during this transition.”

Mr. Blust has over 20 years of accounting and finance experience. Prior to joining the Company in September 2018, Mr. Blust served as the Controller at Vector Solutions, a software company. Mr. Blust also served as CFO for Honeycomb Company of America, an aerospace manufacturer, and as Assistant Controller for Marinemax, a retail boat company. He began his career in public accounting in 2004, serving with both Cherry Bekaert as well as Bobbitt, Pittinger & Company.

Mr. Getman’s departure is not based on any disagreement with the Company regarding accounting principles, practices or financial statement disclosures.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve_
X: @Trulieve

Investor Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Phil Buck, APR, Corporate Communications Manager
+1 (406) 370-6226
Philip.Buck@Trulieve.com

v3.25.0.1
Document and Entity Information
Mar. 06, 2025
Cover [Abstract]  
Document Type 8-K
Document Period End Date Mar. 06, 2025
Entity Registrant Name TRULIEVE CANNABIS CORP.
Entity Incorporation, State or Country Code A1
Entity File Number 000-56248
Entity Tax Identification Number 84-2231905
Entity Address, Address Line One 6749 Ben Bostic Road
Entity Address, City or Town Quincy
Entity Address, State or Province FL
Entity Address, Postal Zip Code 32351
City Area Code 850
Local Phone Number 298-8866
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001754195
Amendment Flag false
Trulieve Cannabis (QX) (USOTC:TCNNF)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Trulieve Cannabis (QX) Charts.
Trulieve Cannabis (QX) (USOTC:TCNNF)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Trulieve Cannabis (QX) Charts.